Cargando…
A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in preclinical models, its role in ER+ BMETs, representing the majority of clinical BMETs, has not been documented. Experiments were un...
Autores principales: | Cheng, Julia N., Frye, Jennifer B., Whitman, Susan A., Kunihiro, Andrew G., Pandey, Ritu, Funk, Janet L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123146/ https://www.ncbi.nlm.nih.gov/pubmed/33923316 http://dx.doi.org/10.3390/ijms22094463 |
Ejemplares similares
-
Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model
por: Cheng, Julia N., et al.
Publicado: (2021) -
Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018) -
The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021) -
Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022) -
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)